Gutry Phil's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Apr 13, 2022
- Accession no.
- 0001209191-22-024362
- Filed
- Apr 13, 2022
- Trade date
- Apr 11, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $20.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gutry PhilCIK 0001653224 | Officer (CHIEF BUSINESS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $4.01 | +$20,050 | 299,941 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.